Page 28 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 15 of 16 Guideline

disseminated TB, including TBM. Cerebrospinal fluid cell 5. Mfinanga S, Chanda D, Kivuyo SL, et al. Cryptococcal meningitis screening and
profiles and protein levels in CM are similar to those seen in community-based early adherence support in people with advanced HIV infection
starting antiretroviral therapy in Tanzania and Zambia: An open-label, randomised
TBM. However, a positive CrAg test or fungal culture is controlled trial. Lancet. 2015;385(9983):2173–2182. https://doi.org/10.1016/
65
S0140-6736(15)60164-7
diagnostic for CM, and concomitant TBM is then less likely. 6. Govender NP, Glencross DK. National coverage of reflex cryptococcal antigen
66
All patients with CM relapse or cryptococcal IRIS should have screening: A milestone achievement in the care of persons with advanced HIV
diagnostic tests performed for concomitant TB with CSF and disease. S Afr Med J. 2018;108(7):534–535. https://doi.org/10.7196/SAMJ.2018.
v108i7.13094
sputum GeneXpert Ultra assay, urinary lipoarabinomannan 7. Larson BA, Rockers PC, Bonawitz R, et al. Screening HIV-infected patients
assay and chest radiograph (although pulmonary TB and with low CD4 counts for cryptococcal antigenemia prior to initiation of
antiretroviral therapy: Cost effectiveness of alternative screening strategies in
cryptococcosis are difficult to distinguish radiologically). South Africa. PLoS One. 2016;11(7):e0158986. https://doi.org/10.1371/journal.
pone.0158986
8. Molloy SF, Kanyama C, Heyderman RS, et al. Antifungal combinations for
Acknowledgements treatment of cryptococcal meningitis in Africa. N Engl J Med. 2018;378(11):1004–
1017. https://doi.org/10.1056/NEJMoa1710922
Competing interests 9. Day J, Imran D, Ganiem AR, et al. CryptoDex: A randomised, double-blind,
placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected
The authors declare that they have no financial or personal adults with cryptococcal meningitis: Study protocol for a randomised control trial.
Trials. 2014;15:441. https://doi.org/10.1186/1745-6215-15-441
relationships which may have inappropriately influenced 10. Govender NP, Meintjes G, Banoo S. Access to flucytosine for HIV-infected patients
them in writing this article. with cryptococcal meningitis – An urgent need. S Afr Med J. 2014;104(9):594–
595. https://doi.org/10.7196/SAMJ.8713
11. National Department of Health. National consolidated guidelines for the
Authors’ contributions prevention of mother-to-child transmission of HIV and the management of HIV
in children, adolescents and adults [homepage on the Internet]. Pretoria, South
N.P.G. and G.M. chaired the guideline panel. P.M., J.N., S.P., Africa: National Department of Health; 2015 [cited 02 September 2019]. Available
from: http://www.health.gov.za/index.php/2014-03-17-09-09-38/policies-and-
D.R. and D.W. drafted sections of the document. N.P.G. guidelines/category/230-2015p.
compiled the guideline document and worked on editing 12. National Department of Health. 2019 ART clinical guidelines for the management
of HIV in adults, pregnancy, adolescents, children, infants and neonates
and reviewing with G.M. The rest of the authors listed [homepage on the Internet]. Pretoria, South Africa: National Department of
contributed equally. Health; 2019 [cited 02 September 2019]. Available from: http://www.health.gov.
za/index.php/2014-03-17-09-09-38/policies- and-guidelines/.
13. Ford N, Shubber Z, Jarvis JN, et al. CD4 cell count threshold for cryptococcal
Ethical considerations antigen screening of HIV-infected individuals: A systematic review and meta-
analysis. Clin Infect Dis. 2018;66(suppl_2):S152–S159. https://doi.org/10.1093/
cid/cix1143
This article followed all ethical standards for a research 14. Tugume L, Rhein J, Hullsiek KH, et al. HIV-associated cryptococcal meningitis
without direct contact with human or animal subjects. occurring at relatively higher CD4 counts. J Infect Dis. 2019;219(6):877–883.
https://doi.org/10.1093/infdis/jiy602
15. Meiring ST, Quan VC, Cohen C, et al. A comparison of cases of paediatric-onset and adult-
Funding information onset cryptococcosis detected through population-based surveillance, 2005–2007.
AIDS. 2012;26(18):2307–2314. https://doi.org/10.1097/QAD.0b013e3283570567
This research received no specific grant from any funding 16. Vallabhaneni S, Longley N, Smith M, et al. Implementation and operational research:
Evaluation of a public-sector, provider-initiated cryptococcal antigen screening and
agency in the public, commercial, or not-for-profit sectors. treatment program, Western Cape, South Africa. J Acquir Immune Defic Syndr.
2016;72(2):e37–e42. https://doi.org/10.1097/QAI.0000000000000976
17. Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care
Data availability statement cryptococcal antigen test on serum, plasma, and urine from patients with HIV-
associated cryptococcal meningitis. Clin Infect Dis. 2011;53(10):1019–1023.
Data sharing is not applicable to this article as no new data https://doi.org/10.1093/cid/cir613
were created or analysed in this study. 18. Wake RM, Britz E, Sriruttan C, et al. High cryptococcal antigen titers in blood are
predictive of subclinical cryptococcal meningitis among human immunodeficiency
virus-infected patients. Clin Infect Dis. 2018;66(5):686–692. https://doi.
org/10.1093/cid/cix872
Disclaimer 19. Meintjes G, Carmona S, Davies N, et al. Adult antiretroviral therapy guidelines
2017. S Afr J HIV Med. 2017;18(1):a776. https://doi.org/10.4102/sajhivmed.
The views and opinions expressed in this article are those of v18i1.776
the authors and do not necessarily reflect the official policy or 20. Rajasingham R, Wake RM, Beyene T, Katende A, Letang E, Boulware DR.
Cryptococcal meningitis diagnostics and screening in the era of point-of-care
position of any affiliated agency of the authors. laboratory testing. J Clin Microbiol. 2019;57(1),pii:e01238–18. https://doi.
org/10.1128/JCM.01238-18
References 21. Wake RM, Govender NP, Omar T, et al. Cryptococcal-related mortality despite
fluconazole pre-emptive treatment in a cryptococcal antigen (CrAg) screen-and-
treat programme. Clin Infect Dis. 2019;June 8,pii:ciz485. https://doi.org/10.1093/
1. Southern African HIV Clinicians Society. Guideline for the prevention, diagnosis cid/ciz485
and management of cryptococcal meningitis among HIV-infected persons: 22. Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after
2013 update. S Afr J HIV Med. 2013;14(2):a82. https://doi.org/10.7196/ diagnosis of cryptococcal meningitis. N Engl J Med. 2014;370(26):2487–2498.
sajhivmed.930. https://doi.org/10.1056/NEJMoa1312884
2. National Institute for Communicable Diseases. GERMS-SA annual report 23. Rhein J, Hullsiek KH, Evans EE, et al. Detrimental outcomes of unmasking
Johannesburg, South Africa [homepage on the Internet]. National Institute for cryptococcal meningitis with recent ART initiation. Open Forum Infect Dis.
Communicable Diseases; 2017 [cited 02 September 2019]. Available from: http:// 2018;5(8):ofy122. https://doi.org/10.1093/ofid/ofy122
www.nicd.ac.za/publications/archives/. 24. Bright PD, Lupiya D, van Oosterhout JJ, Chen A, Harrison TS, Chan AK. The
3. World Health Organization. Guidelines for managing advanced HIV disease and treatment of a pregnant HIV positive patient with cryptococcal meningitis in
rapid initiation of antiretroviral therapy [homepage on the Internet]. Geneva, Malawi. Case report and review of treatment options. Med Mycol Case Rep.
2018;19:9–12. https://doi.org/10.1016/j.mmcr.2017.10.002
Switzerland; 2017 [cited 02 September 2019]. Available from: https://www.who.
int/hiv/pub/guidelines/advanced-HIV-disease/en/. 25. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for
4. World Health Organization. Guidelines for the diagnosis, prevention and the management of cryptococcal disease: 2010 update by the infectious
diseases society of america. Clin Infect Dis. 2010;50(3):291–322. https://doi.
management of cryptococcal disease in HIV-infected adults, adolescents and org/10.1086/649858
children [homepage on the Internet]. Geneva, Switzerland: World Health
Organization; 2018 [cited 02 September 2019]. Available from: https://www. 26. University of Cape Town. South African Medicines Formulary (12th edn). Health
who.int/hiv/pub/guidelines/cryptococcal-disease/en/ and Medical Publishing Group, Pretoria, 2016.
http://www.sajhivmed.org.za 21 Open Access